Showing 381 - 400 results of 492 for search '"Hepatitis C"', query time: 0.05s Refine Results
  1. 381

    Incidence of Severe Hepatotoxicity Related to Antiretroviral Therapy in HIV/HCV Coinfected Patients by Emily L. Heil, Mary L. Townsend, Kenneth Shipp, Amy Clarke, Melissa D. Johnson

    Published 2010-01-01
    “…Hepatotoxicity is a concern in HIV/hepatitis C virus (HCV) coinfected patients due to their underlying liver disease. …”
    Get full text
    Article
  2. 382

    Alaninaminotransferase and specific viral hepatitis markers in the blood of donors by Zh. K. Burkitbayev, G. A. Yesenbayeva, S. A. Abdrakhmanova, Zh. Zh. Bibekov, Ye. B. Zhiburt

    Published 2018-08-01
    “…In the samples received after capillary blood culling the anti-hepatitis C virus antibodies positivity rate was decreased. …”
    Get full text
    Article
  3. 383

    The Role of mTOR Inhibitors in Liver Transplantation: Reviewing the Evidence by Goran B. Klintmalm, Björn Nashan

    Published 2014-01-01
    “…Despite the success of liver transplantation, long-term complications remain, including de novo malignancies, metabolic syndrome, and the recurrence of hepatitis C virus (HCV) and hepatocellular carcinoma (HCC). …”
    Get full text
    Article
  4. 384

    RNA Viruses: ROS-Mediated Cell Death by Mohammad Latif Reshi, Yi-Che Su, Jiann-Ruey Hong

    Published 2014-01-01
    “…This review focuses on RNA viruses and retroviruses, giving particular attention to the human influenza virus, Hepatitis c virus (HCV), human immunodeficiency virus (HIV), and the aquatic Betanodavirus. …”
    Get full text
    Article
  5. 385

    Reversible Pulmonary Arterial Hypertension Associated with Interferon-Beta Treatment for Multiple Sclerosis by E Gibbons, S Promislow, RA Davies, G Chandy, DJ Stewart, V Contreras-Dominguez, C Pugliese, R Dunne, LM Mielniczuk

    Published 2015-01-01
    “…Interferon (IFN) therapy has an important role in the treatment of multiple sclerosis and chronic hepatitis C infection. A few case reports have described an association between IFN therapy and the development of irreversible pulmonary arterial hypertension (PAH), and it is currently listed as a possible drug-induced cause of PAH in the most recent classification of pulmonary hypertension. …”
    Get full text
    Article
  6. 386

    Multiple Comorbid Conditions among Middle-Aged and Elderly Hemophilia Patients: Prevalence Estimates and Implications for Future Care by Aroub A. Khleif, Nidra Rodriguez, Deborah Brown, Miguel A. Escobar

    Published 2011-01-01
    “…The most common conditions identified were chronic hepatitis C, hypertension, HIV, chronic arthropathy, and overweight/obesity. …”
    Get full text
    Article
  7. 387

    Efficacy Comparison of Nitazoxanide Combined with Lactulose versus Lactulose Monotherapy in Managing Overt Hepatic Encephalopathy by Taimoor Hafeez Janjua, Amanat Ali, Sameer Ahmed, Sabeen Shakir, Zunera Rashid, Asma Irfan

    Published 2025-01-01
    “…Results: A total of 150 patients, with a mean age of 44.08 ± 11.31 years were enrolled. Hepatitis C was the predominant aetiology in 81 patients (54%). …”
    Get full text
    Article
  8. 388

    3-(5-Hydroxyphenyl)-5-Phenyl-2-Pyrazolines as Toll-Like Receptor 7 Agonists by Ji Hwan Kim, Seunghyun Ahn, Dongsoo Koh, Young Han Lee, Yoongho Lim, Soon Young Shin

    Published 2023-01-01
    “…Toll-like receptor 7 (TLR7) is an attractive target for developing immune modulators to enhance innate immunity against ssRNA virus infections, including hepatitis C and COVID-19. Ten 3-(5-hydroxyphenyl)-5-phenyl-2-pyrazolines were tested using TLR7 reporter cells, overexpressing TLR7 and the NF-κB-inducible SEAP reporter gene to discover a novel TLR7 agonist enhancing innate immunity. …”
    Get full text
    Article
  9. 389

    Concomitant Nephrotic Syndrome and Cryoglobulinemia in a Case of Malignant Mesothelioma by Kei Nagai, Hiroaki Tachi, Kohei Inoue, Atsushi Ueda

    Published 2022-01-01
    “…Cryoglobulinemia is found in various pathological statuses, such as hepatitis C virus infection but rarely in malignant neoplasms. …”
    Get full text
    Article
  10. 390

    Hepatocellular Carcinoma to the Right Ventricle by George R. Marzouka, Apurva Badheka, Alexis P. Rodriguez, Sandra V. Chaparro

    Published 2014-01-01
    “…We present a case of a 63-year-old man with history of hepatitis C and cirrhosis, which had progressed to HCC. …”
    Get full text
    Article
  11. 391

    Assessment of Some Heavy Metals and Trace Elements in a Sample of Patients with Viral Hepatitis in Baghdad by Najlaa Fattah-Allah Rasheed, Hind Salman Jassim, Ahmad Saadi Hassan

    Published 2022-09-01
    “…One hundred fifty samples of blood were collected from fifty patients with hepatitis B, fifty patients with hepatitis C, and fifty individuals without viral hepatitis as controls at the Gastroenterology and Hepatology Teaching Hospital in Baghdad during the period from November 2021 to March 2022. …”
    Get full text
    Article
  12. 392

    Application and development of biosensors in the detection of transfusion transmitted diseases markers:a review by CHEN Siyi, LIAO Deyu, ZHAO Lin, GAO Feiran, TAN Bin

    Published 2024-12-01
    “…However, there is a risk of transmitting diseases during blood transfusion, such as human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV), etc. To reduce these risks and ensure blood transfusion safety, detection of disease markers in blood transfusion is particularly important. …”
    Get full text
    Article
  13. 393

    Challenges in Providing Treatment and Care for Viral Hepatitis among Individuals Co-Infected with HIV in Resource-Limited Settings by Wirach Maek-a-Nantawat, Anchalee Avihingsanon, Pirapon June Ohata

    Published 2012-01-01
    “…Most of the patients infected with hepatitis C in Thailand have genotype 3 which is significantly related to intravenous drug use whereas, in Vietnam, it is genotype 6. …”
    Get full text
    Article
  14. 394

    Role of Interleukin-28B in clearance of HCV in acute and chronic hepatitis patients in Kirkuk city by Muhannad Abdullah Alazzawy

    Published 2018-07-01
    “…The number of hepatitis patient understudy were 62 hepatitis C (27 acute and 35 chronic) whose ages were between 20-75 years old. …”
    Get full text
    Article
  15. 395

    Urgent Splenectomy after Partial Splenic Embolization in Liver-Transplanted Patient: A Case Report by Jorge Herrador Benito, M. G. Zunzarren, T. Pozancos de Simón, L. Tortolero, R. Latorre Fragua, J. Nuño, E. Lobo

    Published 2012-01-01
    “…Three months after liver transplantation due to hepatitis C virus (HCV) hepatopathy, an HCV relapse was detected, and partial splenic embolization (PSE) was performed prior to antiviral treatment. …”
    Get full text
    Article
  16. 396

    Bardet-Biedl Syndrome with a Kidney Transplant, Esophageal Adenocarcinoma, and Postoperative Complications by Georgi Yankov, Teodora Mihalova, Rosen Petkov, Evgeni Mekov, Stefka Yankova, Danail Petrov

    Published 2019-01-01
    “…The authors present a rare clinical case of a patient with Bardet-Biedl syndrome and chronic kidney disease, who reached end-stage renal disease (ESRD) and underwent a long-term hemodialysis treatment, during which infections with Hepatitis C Virus (HCV) infection and Cytomegalovirus (CMV) infection were established. …”
    Get full text
    Article
  17. 397

    Cytokines and HCV-Related Disorders by Poupak Fallahi, Clodoveo Ferri, Silvia Martina Ferrari, Alda Corrado, Domenico Sansonno, Alessandro Antonelli

    Published 2012-01-01
    “…Cytokines are intercellular mediators involved in viral control and liver damage being induced by infection with hepatitis C virus (HCV). The complex cytokine network operating during initial infection allows a coordinated, effective development of both innate and adaptive immune responses. …”
    Get full text
    Article
  18. 398

    Simeprevir and Sofosbuvir Combination Treatment in a Patient with HCV Cirrhosis and HbS Beta 0-Thalassemia: Efficacy and Safety despite Baseline Hyperbilirubinemia by Nikolaos Papadopoulos, Melanie Deutsch, Athanasios Georgalas, Helias Poulakidas, Lazaros Karnesis

    Published 2016-01-01
    “…We describe a 51-year-old female patient with HbS beta 0-thalassemia and recently diagnosed compensated cirrhosis due to chronic hepatitis C infection. Laboratory evaluation revealed total bilirubin: 2.7 mg/dL and serum HCV-RNA 137.204 IU/mL. …”
    Get full text
    Article
  19. 399

    HCV Proteins and Immunoglobulin Variable Gene (IgV) Subfamilies in HCV-Induced Type II Mixed Cryoglobulinemia: A Concurrent Pathogenetic Role by Giuseppe Sautto, Nicasio Mancini, Laura Solforosi, Roberta A. Diotti, Massimo Clementi, Roberto Burioni

    Published 2012-01-01
    “…The association between hepatitis C virus (HCV) infection and type II mixed cryoglobulinemia (MCII) is well established, but the role played by distinct HCV proteins and by specific components of the anti-HCV humoral immune response remains to be clearly defined. …”
    Get full text
    Article
  20. 400

    Virological Mechanisms in the Coinfection between HIV and HCV by Maria Carla Liberto, Emilia Zicca, Grazia Pavia, Angela Quirino, Nadia Marascio, Carlo Torti, Alfredo Focà

    Published 2015-01-01
    “…Due to shared transmission routes, coinfection with Hepatitis C Virus (HCV) is common in patients infected by Human Immunodeficiency Virus (HIV). …”
    Get full text
    Article